Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3813
-0.0036 (-0.94%)
Jun 20, 2025, 11:28 AM - Market open
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $22.59 million as of June 20, 2025. Its market cap has decreased by -89.06% in one year.
Market Cap
22.59M
Enterprise Value
-26.60M
1-Year Change
-89.06%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $22.59M, a decrease of -93.81%. That is a compound annual growth rate of -50.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 22.81M | -31.43% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 333.14B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |